Press release
Global Peptide Therapeutics Market is Predicted to Reach USD 103 Billion By 2030 Registering a CAGR of 10% | Infinium Global Research
To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/628
Market Insight:
The global peptide therapeutics market, valued at approximately USD 45 billion in 2022, is projected to escalate to nearly USD 103 billion by 2030, exhibiting a robust CAGR of around 10% during the forecast period from 2023 to 2030.
Peptides, short chains of amino acids with diverse cellular functions, hold immense therapeutic potential. Their utility in combatting infections and signaling processes drives market growth. The market's trajectory is bolstered by the rising prevalence of metabolic disorders and cancer, escalated investments in R&D for new drugs, and advancements in peptide therapeutic technologies. Chronic diseases like diabetes, cardiovascular diseases, and cancer have been reported as major causes of global death and disability, fueling the demand for peptide therapeutics.
Market Dynamics:
Recent years have witnessed substantial growth in the global peptide therapeutics market due to surging cancer cases and increasing metabolic disorders. The market is poised for continued expansion driven by ongoing research activities and novel drug development. However, stringent regulatory processes for drug approval might pose challenges. Nevertheless, the rising incidence of metabolic disorders globally is anticipated to present multiple growth opportunities. Market players focus on developing innovative peptide-based drugs to address unmet medical needs, further propelled by advancements in drug delivery systems and technologies.
Regional Analysis:
North America holds the largest market share and is expected to maintain its dominance owing to increased awareness of peptide-based therapeutics and a thriving biotechnology sector. Europe, the second-largest market, experiences growth due to emerging pharmaceutical and biotech firms. Meanwhile, Asia-Pacific is poised to exhibit the highest CAGR in the upcoming years, attributed to sophisticated healthcare infrastructure and a rising population of cancer patients and metabolic disorders.
Segments Covered:
The report segments the global peptide therapeutics market based on product type (generic, branded), application (gastrointestinal disorders, neurological disorders, cancer, etc.), and route of administration (parenteral, oral, etc.).
Companies Profiled:
Key market players such as Teva Pharmaceutical Industries Ltd., Pfizer Inc., GSK plc, and others are extensively profiled in the report, offering insights into their contributions shaping the evolving peptide therapeutics market.
Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/market-reports/customization/628
Table of Content
Chapter 1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
Chapter 2. Executive Summary
2.1. Peptide Therapeutics Market Highlights
2.2. Peptide Therapeutics Market Projection
2.3. Peptide Therapeutics Market Regional Highlights
Chapter 3. Global Peptide Therapeutics Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter`s Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Product Type
3.4.2. IGR-Growth Matrix Analysis by Application
3.4.3. IGR-Growth Matrix Analysis by Route of Administration
3.4.4. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Peptide Therapeutics Market
Chapter 4. Peptide Therapeutics Market Macro Indicator Analysis
Chapter 5. Company Profiles and Competitive Landscape
5.1. Competitive Landscape in the Global Peptide Therapeutics Market
5.2. Companies Profiles
5.2.1. Teva Pharmaceutical Industries Ltd.
5.2.2. Takeda Pharmaceutical Company Limited
5.2.3. Sanofi
5.2.4. Pfizer Inc.
5.2.5. Novartis AG
5.2.6. GSK plc
5.2.7. F. Hoffmann-La Roche Ltd
5.2.8. Lilly
5.2.9. Bachem
5.2.10. Amgen Inc.
Chapter 6. Global Peptide Therapeutics Market by Product Type
6.1. Generic
6.2. Branded
Chapter 7. Global Peptide Therapeutics Market by Application
7.1. Gastrointestinal Disorders
7.2. Neurological Disorders
7.3. Metabolic Disorders
7.4. Cancer
7.5. Other Applications
Chapter 8. Global Peptide Therapeutics Market by Route of Administration
8.1. Parenteral
8.2. Oral
8.3. Other Routes of Administration
Chapter 9. Global Peptide Therapeutics Market by Region 2023-2030
9.1. North America
9.1.1. North America Peptide Therapeutics Market by Product Type
9.1.2. North America Peptide Therapeutics Market by Application
9.1.3. North America Peptide Therapeutics Market by Route of Administration
9.1.4. North America Peptide Therapeutics Market by Country
9.1.4.1. The U.S. Peptide Therapeutics Market
9.1.4.1.1. The U.S. Peptide Therapeutics Market by Product Type
9.1.4.1.2. The U.S. Peptide Therapeutics Market by Application
9.1.4.1.3. The U.S. Peptide Therapeutics Market by Route of Administration
9.1.4.2. Canada Peptide Therapeutics Market
9.1.4.2.1. Canada Peptide Therapeutics Market by Product Type
9.1.4.2.2. Canada Peptide Therapeutics Market by Application
9.1.4.2.3. Canada Peptide Therapeutics Market by Route of Administration
9.1.4.3. Mexico Peptide Therapeutics Market
9.1.4.3.1. Mexico Peptide Therapeutics Market by Product Type
9.1.4.3.2. Mexico Peptide Therapeutics Market by Application
9.1.4.3.3. Mexico Peptide Therapeutics Market by Route of Administration
9.2. Europe
9.2.1. Europe Peptide Therapeutics Market by Product Type
9.2.2. Europe Peptide Therapeutics Market by Application
9.2.3. Europe Peptide Therapeutics Market by Route of Administration
9.2.4. Europe Peptide Therapeutics Market by Country
9.2.4.1. Germany Peptide Therapeutics Market
9.2.4.1.1. Germany Peptide Therapeutics Market by Product Type
9.2.4.1.2. Germany Peptide Therapeutics Market by Application
9.2.4.1.3. Germany Peptide Therapeutics Market by Route of Administration
9.2.4.2. United Kingdom Peptide Therapeutics Market
9.2.4.2.1. United Kingdom Peptide Therapeutics Market by Product Type
9.2.4.2.2. United Kingdom Peptide Therapeutics Market by Application
9.2.4.2.3. United Kingdom Peptide Therapeutics Market by Route of Administration
9.2.4.3. France Peptide Therapeutics Market
9.2.4.3.1. France Peptide Therapeutics Market by Product Type
9.2.4.3.2. France Peptide Therapeutics Market by Application
9.2.4.3.3. France Peptide Therapeutics Market by Route of Administration
9.2.4.4. Italy Peptide Therapeutics Market
9.2.4.4.1. Italy Peptide Therapeutics Market by Product Type
9.2.4.4.2. Italy Peptide Therapeutics Market by Application
9.2.4.4.3. Italy Peptide Therapeutics Market by Route of Administration
9.2.4.5. Rest of Europe Peptide Therapeutics Market
9.2.4.5.1. Rest of Europe Peptide Therapeutics Market by Product Type
9.2.4.5.2. Rest of Europe Peptide Therapeutics Market by Application
9.2.4.5.3. Rest of Europe Peptide Therapeutics Market by Route of Administration
9.3. Asia Pacific
9.3.1. Asia Pacific Peptide Therapeutics Market by Product Type
9.3.2. Asia Pacific Peptide Therapeutics Market by Application
9.3.3. Asia Pacific Peptide Therapeutics Market by Route of Administration
9.3.4. Asia Pacific Peptide Therapeutics Market by Country
9.3.4.1. China Peptide Therapeutics Market
9.3.4.1.1. China Peptide Therapeutics Market by Product Type
9.3.4.1.2. China Peptide Therapeutics Market by Application
9.3.4.1.3. China Peptide Therapeutics Market by Route of Administration
9.3.4.2. Japan Peptide Therapeutics Market
9.3.4.2.1. Japan Peptide Therapeutics Market by Product Type
9.3.4.2.2. Japan Peptide Therapeutics Market by Application
9.3.4.2.3. Japan Peptide Therapeutics Market by Route of Administration
9.3.4.3. India Peptide Therapeutics Market
9.3.4.3.1. India Peptide Therapeutics Market by Product Type
9.3.4.3.2. India Peptide Therapeutics Market by Application
9.3.4.3.3. India Peptide Therapeutics Market by Route of Administration
9.3.4.4. South Korea Peptide Therapeutics Market
9.3.4.4.1. South Korea Peptide Therapeutics Market by Product Type
9.3.4.4.2. South Korea Peptide Therapeutics Market by Application
9.3.4.4.3. South Korea Peptide Therapeutics Market by Route of Administration
9.3.4.5. Australia Peptide Therapeutics Market
9.3.4.5.1. Australia Peptide Therapeutics Market by Product Type
9.3.4.5.2. Australia Peptide Therapeutics Market by Application
9.3.4.5.3. Australia Peptide Therapeutics Market by Route of Administration
9.3.4.6. Rest of Asia-Pacific Peptide Therapeutics Market
9.3.4.6.1. Rest of Asia-Pacific Peptide Therapeutics Market by Product Type
9.3.4.6.2. Rest of Asia-Pacific Peptide Therapeutics Market by Application
9.3.4.6.3. Rest of Asia-Pacific Peptide Therapeutics Market by Route of Administration
9.4. RoW
9.4.1. RoW Peptide Therapeutics Market by Product Type
9.4.2. RoW Peptide Therapeutics Market by Application
9.4.3. RoW Peptide Therapeutics Market by Route of Administration
9.4.4. RoW Peptide Therapeutics Market by Sub-region
9.4.4.1. Latin America Peptide Therapeutics Market
9.4.4.1.1. Latin America Peptide Therapeutics Market by Product Type
9.4.4.1.2. Latin America Peptide Therapeutics Market by Application
9.4.4.1.3. Latin America Peptide Therapeutics Market by Route of Administration
9.4.4.2. Middle East Peptide Therapeutics Market
9.4.4.2.1. Middle East Peptide Therapeutics Market by Product Type
9.4.4.2.2. Middle East Peptide Therapeutics Market by Application
9.4.4.2.3. Middle East Peptide Therapeutics Market by Route of Administration
9.4.4.3. Africa Peptide Therapeutics Market
9.4.4.3.1. Africa Peptide Therapeutics Market by Product Type
9.4.4.3.2. Africa Peptide Therapeutics Market by Application
9.4.4.3.3. Africa Peptide Therapeutics Market by Route of Administration
More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/market-reports/enquiry/628
Reasons to Buy this Report:
=> Comprehensive analysis of global as well as regional markets of peptide therapeutics.
=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.
=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.
=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.
2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027
About Infinium Global Research:
Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.
Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Peptide Therapeutics Market is Predicted to Reach USD 103 Billion By 2030 Registering a CAGR of 10% | Infinium Global Research here
News-ID: 3310730 • Views: …
More Releases from Infinium Global Research LLP
Saudi Arabia Healthcare Cybersecurity Market is Expected to Reach USD 1650 Milli …
The Saudi Arabia healthcare cybersecurity market has entered a phase of accelerated growth, driven by the country's ongoing digital transformation and the rapid adoption of advanced healthcare IT platforms. Valued at USD 540 million in 2023, the market is projected to reach USD 1,650 million by 2032, expanding at a CAGR of 15% during 2024-2032. This growth is fueled by the Kingdom's National e-Health Strategy, rising cyberthreats targeting healthcare systems,…
Global Aviation Fuel Market Outlook 2024-2032: Growth from USD 289.34 Billion to …
The aviation fuel market has expanded steadily in recent years, driven by rising global air traffic, economic improvements, and the rapid expansion of commercial and cargo aviation networks. The market was valued at USD 289.34 billion in 2023 and is projected to reach USD 437.34 billion by 2032, reflecting stable expansion supported by increasing aircraft operations, modernization of fleets, and the growing need for reliable fuel logistics. Key growth drivers…
United States Beauty and Wellness Market is Expected to Reach USD 143.27 Million …
The United States beauty and wellness market continues to evolve rapidly, shaped by shifting consumer priorities, rising disposable incomes, digital-first retail strategies, and the strong influence of self-care culture. With a valuation of USD 97 billion in 2023, the market is firmly positioned as one of the world's largest and most dynamic consumer-driven sectors. Increased awareness of holistic wellbeing, demand for clean beauty solutions, and adoption of premium skincare and…
United States Pharmerging Market is Expected to Reach USD 1172.82 Billion in 203 …
The United States pharmerging market has emerged as one of the fastest-growing components of the broader healthcare and pharmaceutical ecosystem, driven by rapid advancements in drug manufacturing, rising healthcare expenditure, and a surge in lifestyle-related diseases. Valued at USD 540 billion in 2023, the market is projected to reach USD 1172.82 billion by 2032, expanding at a CAGR of 9% during 2024-2032. This growth reflects the country's robust pharmaceutical infrastructure…
More Releases for Peptide
ShiLai Peptide to Invest $32 Million in State-of-the-Art Peptide Laboratory in H …
ShiLai Peptide's CEO, Luo Binhua, said the investment reflects the company's commitment to a "new science model" that integrates research-driven development, controlled production, and specialized customer support.
ShiLai Peptide [https://retatrutidesupplier.com/], a leading provider of high-purity, customizable research peptides, announced plans to invest $32 million to build a state-of-the-art peptide research and production laboratory in Hangzhou. The facility is designed to meet world-class GMP standards, aiming to strengthen ShiLai's global supply of…
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
